{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:45:13Z","timestamp":1791402313775,"version":"4.3.3"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"8","funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["UM1AI104681"],"award-info":[{"award-number":["UM1AI104681"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8,1]]},"DOI":"10.1093\/jac\/dkx133","type":"journal-article","created":{"date-parts":[[2017,5,17]],"date-time":"2017-05-17T07:08:39Z","timestamp":1495004919000},"page":"2359-2367","source":"Crossref","is-referenced-by-count":79,"title":["Randomized comparison of liposomal amphotericin B versus placebo to prevent invasive mycoses in acute lymphoblastic leukaemia"],"prefix":"10.1093","volume":"72","author":[{"given":"Oliver A.","family":"Cornely","sequence":"first","affiliation":[{"name":"Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Department I of Internal Medicine, Clinical Trials Centre Cologne (ZKS), Center for Integrated Oncology (CIO K\u00f6lnBonn), German Centre for Infection Research (DZIF), partner site Bonn-Cologne, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaut","family":"Leguay","sequence":"additional","affiliation":[{"name":"Service d'h\u00e9matologie clinique et Th\u00e9rapie cellulaire, H\u00f4pital du Haut-L\u00e9v\u00e8que, CHU de Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Maertens","sequence":"additional","affiliation":[{"name":"KU Leuven-University of Leuven, Department of Microbiology and Immunology, University Hospitals Leuven, Department of Hematology, B-3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J. G. T.","family":"Vehreschild","sequence":"additional","affiliation":[{"name":"Department I of Internal Medicine, University of Cologne, Cologne, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achilles","family":"Anagnostopoulos","sequence":"additional","affiliation":[{"name":"Haematology Department \u2013 BMT Unit, George Papanicolaou Hospital, Thessaloniki 57010, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Castagnola","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Verga","sequence":"additional","affiliation":[{"name":"Ospedale San Gerardo, Monza, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Rieger","sequence":"additional","affiliation":[{"name":"Medizinische Klinik und Poliklinik III, Klinikum der Universit\u00e4t M\u00fcnchen, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Kondakci","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr H\u00e4matologie, Onkologie und klin. Immunologie, Universit\u00e4tsklinikum D\u00fcsseldorf, D\u00fcsseldorf, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"H\u00e4rter","sequence":"additional","affiliation":[{"name":"Zentrum f\u00fcr Hormon- und Stoffwechselerkrankungen und Infektiologie, MVZ Endokrinologikum Ulm, and Department of Internal Medicine III, Ulm University Hospital Medical Center, Ulm, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael F.","family":"Duarte","sequence":"additional","affiliation":[{"name":"Department of Hematology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid 28222, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardino","family":"Allione","sequence":"additional","affiliation":[{"name":"Hematology, Ospedale S. Giovanni Battista Molinette, Torino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Cordonnier","sequence":"additional","affiliation":[{"name":"AP-HP-Henri Mondor, Hematology Department and University Paris-Est Creteil, F-94010 Cr\u00e9teil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus Peter","family":"Heussel","sequence":"additional","affiliation":[{"name":"Thoraxklinik, Universit\u00e4tsklinikum Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Orla","family":"Morrissey","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Alfred Health and Monash University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir G.","family":"Agrawal","sequence":"additional","affiliation":[{"name":"Division of Haemato-Oncology, St Bartholomew's Hospital, Barts Cancer Institute, Queen Mary University, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Peter","family":"Donnelly","sequence":"additional","affiliation":[{"name":"Department of Haematology, Radboud UMC, Nijmegen, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Bresnik","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Hawkins","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Will","family":"Garner","sequence":"additional","affiliation":[{"name":"Gilead Sciences, Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"G\u00f6kbuget","sequence":"additional","affiliation":[{"name":"Department of Medicine II, University Hospital, Goethe University, Frankfurt, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the AmBiGuard Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,5,30]]},"reference":[{"key":"key\n\t\t\t\t20180328152520_dkx133-B1","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1200\/JCO.2010.30.1382","article-title":"Modern therapy of acute lymphoblastic leukemia","volume":"29","author":"Bassan","year":"2011","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180328152520_dkx133-B2","first-page":"1068","article-title":"The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study","volume":"91","author":"Pagano","year":"2006","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t20180328152520_dkx133-B3","doi-asserted-by":"crossref","first-page":"e462","DOI":"10.3324\/haematol.2015.126698","article-title":"Epidemiology of invasive fungal disease in lymphoproliferative disorders","volume":"100","author":"Teng","year":"2015","journal-title":"Haematologica"},{"key":"key\n\t\t\t\t20180328152520_dkx133-B4","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"de Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328152520_dkx133-B5","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2165\/00003495-200868140-00002","article-title":"Patients at high risk of invasive fungal infections: when and how to treat","volume":"68","author":"R\u00fcping","year":"2008","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20180328152520_dkx133-B6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/jac\/dkv343","article-title":"Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: a multicentre audit","volume":"71","author":"Doan","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328152520_dkx133-B7","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.3109\/10428194.2016.1154957","article-title":"Invasive fungal diseases in patients with acute lymphoid leukemia","volume":"57","author":"Nicolato","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"key\n\t\t\t\t20180328152520_dkx133-B8","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1080\/10428194.2016.1204652","article-title":"Epidemiology of invasive fungal infections during induction therapy in adults with acute lymphoblastic leukemia: a GRAALL-2005 study","volume":"58","author":"Mariette","year":"2016","journal-title":"Leuk Lymphoma"},{"key":"key\n\t\t\t\t20180328152520_dkx133-B9","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00277-014-2108-y","article-title":"Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology","volume":"93","author":"Tacke","year":"2014","journal-title":"Ann Hematol"},{"key":"key\n\t\t\t\t20180328152520_dkx133-B10","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328152520_dkx133-B11","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(07)60605-9","article-title":"Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial","volume":"369","author":"Kuse","year":"2007","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328152520_dkx133-B12","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1086\/514341","article-title":"Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)","volume":"44","author":"Cornely","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180328152520_dkx133-B13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12371","article-title":"ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20180328152520_dkx133-B14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/jac\/49.suppl_1.21","article-title":"AmBisome: liposomal formulation, structure, mechanism of action and pre-clinical experience","volume":"49","author":"Adler-Moore","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20180328152520_dkx133-B15","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1128\/AAC.46.3.828-833.2002","article-title":"Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans","volume":"46","author":"Bekersky","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328152520_dkx133-B16","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1128\/AAC.42.9.2391","article-title":"Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients","volume":"42","author":"Walsh","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328152520_dkx133-B17","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/annonc\/mdl128","article-title":"Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial","volume":"17","author":"Penack","year":"2006","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t20180328152520_dkx133-B18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijantimicag.2007.10.001","article-title":"Safety of a weekly high dose of liposomal amphotericin B for prophylaxis of invasive fungal infection in immunocompromised patients: PROPHYSOME Study","volume":"31","author":"Cordonnier","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20180328152520_dkx133-B19","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/cncr.11094","article-title":"Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome","volume":"97","author":"Mattiuzzi","year":"2003","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20180328152520_dkx133-B20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj.bmt.1701543","article-title":"Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study","volume":"23","author":"Kelsey","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"key\n\t\t\t\t20180328152520_dkx133-B21","first-page":"577","article-title":"Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients","volume":"12","author":"Tollemar","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"key\n\t\t\t\t20180328152520_dkx133-B22","volume-title":"Common Terminology Criteria for Adverse Events (CTCAE), Version 4.03","author":"National Cancer Institute","year":"2010"},{"key":"key\n\t\t\t\t20180328152520_dkx133-B23","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/annonc\/mdr407","article-title":"Diagnosis of invasive fungal infections in hematology and oncology\u2014guidelines from the Infectious Diseases Working Party in Haematology and Oncology of the German Society for Haematology and Oncology (AGIHO)","volume":"23","author":"Ruhnke","year":"2012","journal-title":"Ann Oncol"},{"key":"key\n\t\t\t\t20180328152520_dkx133-B24","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1056\/NEJM199203263261301","article-title":"A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation","volume":"326","author":"Goodman","year":"1992","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328152520_dkx133-B25","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1093\/infdis\/171.6.1545","article-title":"Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation\u2014a prospective, randomized, double-blind study","volume":"171","author":"Slavin","year":"1995","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180328152520_dkx133-B26","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1128\/AAC.00265-11","article-title":"Population pharmacokinetics of liposomal amphotericin B and caspofungin in allogeneic hematopoietic stem cell recipients","volume":"56","author":"W\u00fcrthwein","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20180328152520_dkx133-B27","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1128\/AAC.00686-11","article-title":"Wild-type MIC distributions and epidemiological cutoff values for amphotericin B and Aspergillus spp. for the CLSI broth microdilution method (M38-A2 document)","volume":"55","author":"Espinel-Ingroff","year":"2011","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/72\/8\/2359\/24332256\/dkx133.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T15:23:35Z","timestamp":1569338615000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/72\/8\/2359\/3858268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,30]]},"references-count":27,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,5,30]]},"published-print":{"date-parts":[[2017,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx133","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,8]]},"published":{"date-parts":[[2017,5,30]]}}}